PillSafe Founders' Interview Featured on Bloomberg, Fox Business, and Nasdaq

December 17, 2024 3:30 PM

In an exclusive in-depth interview broadcast on Bloomberg, Fox Business and Nasdaq, PillSafe's founders, Dr. John Barr and Jim Patton, discussed how its smart pill delivery system targets the critical issues of patient medicine monitoring and unused prescriptions, identified as key factors driving opioid misuse. Their revolutionary, disruptive technology helps to ensure safety and prescription compliance in the fight against opioids and other...

Read more

Quest Diagnostics Advances Environmental Stewardship With Renewable Energy Initiatives, Waste Reduction, and ISO 14001 Certifications in 2023

December 17, 2024 3:10 PM

NORTHAMPTON, MA / ACCESSWIRE / December 17, 2024 / Quest DiagnosticsOriginally published in Quest Diagnostics' 2023 Corporate Responsibility ReportMinimizing our environmental impactOur work to minimize our environmental impact starts within our walls. We have taken and continue to take steps to lower our carbon footprint by improving the energy efficiency of operations in our facilities as well as our logistics and transportation footprint. In...

Read more

Owen Mumford, Inc. Launches Injection Pen Training Video for Healthcare Professionals

December 17, 2024 2:00 PM

Owen Mumford Inc. is proud to announce the release of a new unique Injection Pen Training Video. Developed in collaboration with consultant pharmacists and nursing professionals, the video addresses critical steps when clinically administering insulin via injection pens and is particularly beneficial for healthcare providers in long-term care, acute care, and alternate care sites.The use of injection pens can be complex, resulting in the...

Read more

Rehab.com Announces Dr. Sylvie Stacy as New Medical Officer

December 17, 2024 1:50 PM

As the addiction crisis continues to grow throughout the United States, Rehab.com is firmly committed to providing quality resources and an extensive directory of over 25,000 recovery centers for those seeking treatment.To ensure Rehab.com remains on the cutting edge of recovery trends and medical breakthroughs, they have recently welcomed Dr. Sylvie Stacy as their new Medical Officer. In this role, Dr. Stacy will review all medical and...

Read more

Theranexus and Exeltis (Insud Pharma) Announce Licensing Agreement to Commercialize Theranexus Tx01 for Two Rare Neurological Disorders

December 17, 2024 12:45 PM

LYON, FRANCE and MADRID, SPAIN / ACCESSWIRE / December 17, 2024 / Theranexus, a biopharmaceutical company innovating in the treatment of rare neurological diseases, and Exeltis, a global pharmaceutical company and part of the Insud Pharma group, are pleased to announce the execution of a license and supply agreement to commercialize Theranexus' TX01, a novel formulation of a compound already approved in the indication for the treatment of rare...

Read more

Theranexus Presents an Update of its Cash Position and Financing Horizon

December 17, 2024 12:45 PM

LYON, FRANCE / ACCESSWIRE / December 17, 2024 / Theranexus, a biopharmaceutical company innovating in the treatment of rare neurological diseases (the "Company"), today presents an update of its cash position as of 12 December 2024 and its cash flow horizon until the end of the first quarter of 2026.Total available funds on 12 December 2024 stood at €1.5 M compared with €1.9 M on 30 September 2024. The Company is expecting its position to...

Read more

Glidewell Opens Applications for 5th Annual Guiding Leaders Program

December 17, 2024 12:00 PM

Glidewell is proud to announce the return of the Guiding Leaders program in 2025. Applications are now open for this exclusive business and leadership development program, designed to empower practicing women dentists to achieve their personal and professional goals. Guiding Leaders is a monthly, in-person program held at the Glidewell campus in Southern California from May to October.As a comprehensive experience, the Guiding Leaders program...

Read more

Lt. Col. Scott Flurry's Final Mission

December 17, 2024 10:00 AM

In a final act of generosity, Lt. Col. Michael "Scott" Flurry-a devoted Marine, husband, and father of four-overcame seemingly impossible odds to become an organ, eye, and tissue donor.In the U.S., only 3 in 1,000 deaths occur in a way that allows for donation after death. Scott faced an even greater challenge-after suffering an unexpected heart attack, he was declared brain-dead in Norway, more than 1,100 miles away from home. Despite the...

Read more

Cellev8 Nutrition Files Two Patents at US Trademark and Patent Office

December 17, 2024 9:30 AM

Cellev8 Nutrition Inc (OTC PINK:CELV), a pioneer in Superoxide Dismutase (SOD) based supplements, has announced the filing of two patents to protect its groundbreaking delivery systems. These patents are set to revolutionize the company's product lines and enhance the proprietary transport of SOD and other powerful ingredients throughout the body to enhance wellness, and promote health and anti aging from cellular levels.Advancing Supplement...

Read more

Ascelia Pharma Announces Acceptance of SPARKLE Phase 3 Data for Presentation at the Society of Abdominal Radiology Congress 2025

December 17, 2024 9:30 AM

Ascelia Pharma (STO:ACE), a biotech focused on improving the life of people living with rare cancer conditions, today announced that two scientific abstracts with clinical data from the SPARKLE Phase 3 study with Orviglance have been accepted as an oral presentation and a scientific poster at the Society of Abdominal Radiology Congress, taking place from 16-21 February 2025 in Tucson, AZ, US.The two abstracts highlight the positive outcomes of...

Read more

Esteemed Harvard Medical School Professor Dr. Michael Gibson Appointed Chief Medical Advisor at Lexaria Bioscience

December 17, 2024 9:10 AM

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces the appointment of Dr. Michael Gibson as its new Chief Medical Advisor. Dr. Gibson will collaborate directly with President John Docherty as Lexaria's patented DehydraTECH drug delivery platform continues to expand its applications in GLP-1 and hypertension.C. Michael Gibson M.S., M.D., is an interventional...

Read more

Med Holdings Group Inc. (OTC PINK:YUKA) Announces Exciting New Developments to Drive Growth

December 17, 2024 8:30 AM

Med Holdings Group Inc. (OTC PINK:YUKA), a leader in health and wellness solutions, is thrilled to announce significant advancements within its MedSmart Wellness Centers subsidiary. These developments position the company for unprecedented growth and further solidify its role as a pioneer in longevity medicine.Introduction of Stem Cell TechnologyMedSmart Wellness Centers is proud to partner with American Cell Technology to introduce cutting-edge...

Read more

FDA Approves Orphan-Drug Designation for Jaguar Health’s Crofelemer for Treatment of Diarrhea in Cholera

December 17, 2024 8:30 AM

Jaguar Health(NASDAQ:JAGX) (Jaguar) family company Napo Pharmaceuticals (Napo) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan-drug designation (ODD) to crofelemer, the company's novel plant-based prescription drug, for treatment of diarrhea in cholera."We are very pleased that crofelemer has been granted orphan-drug designation for this important indication," said Steven King, PhD, Jaguar's Chief Sustainable...

Read more

Nitraflex SPORT Achieves Informed Sport Certification

December 17, 2024 8:15 AM

MONROE, CT / ACCESSWIRE / December 17, 2024 / With its clinically dosed ingredients and Informed Sport certification, Nitraflex® SPORT is safer for athletes and designed for all fitness enthusiasts who demand high performance without the worry of banned substances. This powerful pre-workout enables users to push through their toughest sessions, exemplifying the brand's mantra to COMPETE HARDER®.Nitraflex® SPORT is now available on GATsport.com...

Read more

Is Buccal Fat Removal for Everyone? Philadelphia Facial Plastic Surgeon Breaks Down the Myths

December 17, 2024 8:00 AM

Dr. Kirk Lozada, a double-board certified facial plastic surgeon, is raising awareness about buccal fat removal, a popular cosmetic procedure designed to enhance facial definition. In his latest announcement, Dr. Lozada addresses misconceptions surrounding the buccal fat removal procedure and clarifies who is best suited for it. This initiative seeks to empower individuals with accurate information to make informed decisions about their...

Read more

UniDoc Health Corp. Reflects on a Year of Growth and Innovation

December 17, 2024 7:30 AM

UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc," or the "Company"), an innovator in the eHealth sector, is proud to present its year in review, highlighting a series of achievements that underscore its progress toward transforming healthcare delivery. From partnerships to technological advancements, UniDoc has laid a foundation for continued growth and commercialization in 2025 and beyond.Key Takeaways:Secured partnerships with...

Read more

Recora's Virtual Cardiac Rehabilitation Program Demonstrates Significant Clinical and Cost Benefits in Pivotal Study

December 17, 2024 7:00 AM

A study published in the Journal of the American Heart Association has demonstrated the efficacy and cost savings of Recora's virtual cardiac rehabilitation (VCR) program. The research, conducted in collaboration with Geisinger Health System, provides compelling evidence that VCR can deliver superior outcomes compared to traditional center-based cardiac rehabilitation (CBCR) while also reducing overall healthcare costs. Cardiac rehabilitation is...

Read more

Dr. Nicole Schrader Highlights the Transformative Benefits of Combining Facelift With Complementary Facial Procedures

December 17, 2024 7:00 AM

New Jersey facial plastic surgeon Dr. Nicole Schrader shares groundbreaking perspectives on the transformative effects of combining facelift surgery with complementary facial rejuvenation techniques. Known for her artistic approach and patient-focused care, Dr. Schrader's recommendations focus on tailoring procedures, such as eyelid lifts, brow lifts, and fat transfers, to support the facelift's results. The goal is to create a seamless,...

Read more

Electrophysiology Market 2024 to 2034: North America Leads in Market Share and CAGR | Future Market Insights, Inc.

December 17, 2024 5:30 AM

The global Electrophysiology Market is expected to experience robust growth from 2024 to 2034, driven by advancements in medical technology, rising prevalence of cardiovascular diseases, and increased demand for minimally invasive procedures. The market size in 2024 is projected to be USD 4,350.7 billion and is expected to reach USD 9,078.4 billion by 2034, growing at a compound annual growth rate (CAGR) of 7.6%. This growth is primarily fueled...

Read more

Ondine Commencing US Phase 3 Clinical Trial

December 17, 2024 2:00 AM

Ondine Biomedical Inc. (LON:OBI), a Canadian life sciences company pioneering light-activated antimicrobial treatments, announces the imminent start of the LANTERN Phase 3 clinical trial of its novel nasal photodisinfection technology, branded as Steriwave® outside the US. The U.S. Food and Drug Administration (FDA) has raised no objections to starting the study during its statutory 30-day review period of the Company's Investigational New Drug...

Read more